Form 4: Guardant Health Director Steve Krognes Increases Stake Through RSU Vesting

Guardant Health, Inc. Director Steve Krognes has acquired 6,674 shares of common stock through the vesting of restricted stock units, increasing his direct beneficial ownership to 17,665 shares.

Summary

• Steve E. Krognes, a Director at Guardant Health, Inc. (GH), reported the acquisition of 6,674 shares of common stock.
• The transaction occurred on June 12, 2025, and was reported on June 16, 2025.
• The shares were acquired at a price of $0, indicating they were obtained through the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Mr. Krognes directly beneficially owns 17,665 shares of Guardant Health common stock.
• The Restricted Stock Units vested in full on the one-year anniversary of their grant date, June 12, 2024, or the date of the next annual stockholders meeting, whichever was earlier.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 6

Explanation: Slightly positive. The increase in a director's beneficial ownership, even through vesting, generally signals continued alignment with shareholder interests and confidence in the company, especially when conducted under a 10b5-1 plan.

Positives

• The acquisition of shares by a director, even through RSU vesting, increases their direct ownership in the company, aligning their interests more closely with those of shareholders.
• The transaction was conducted under a Rule 10b5-1(c) plan, which demonstrates a pre-planned and transparent approach to insider stock transactions.

Future Outlook

The document primarily reports a past insider transaction and does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the pre-scheduled vesting of RSUs.

Industry Context

This Form 4 filing is specific to an individual director's stock transaction and does not provide broader insights into Guardant Health's industry position, market trends, or competitive landscape. It is a routine disclosure of insider ownership changes.

Corporate Governance

Stakeholder Impact

• Shareholders: The increase in a director's beneficial ownership through RSU vesting can be viewed positively as it aligns management's interests with those of shareholders, potentially signaling confidence in the company's long-term prospects.

Key Dates

Keywords

Guardant Health, GH, SEC Form 4, Insider Transaction, Director Stock Acquisition, Steve Krognes, RSU Vesting, Common Stock, Corporate Governance, Rule 10b5-1